EGFR and neoplasm: The use of quantitative, single-molecule-based imaging techniques to probe the effects of drug treatment on EGFR will complement the NGS approach by providing a functional readout that can potentially detect genetic variants (of different allelic fractions) that break through as the tumor subclones evolve.